Clinical trials have not fundamentally changed over the past 20 years, but there have been signs that practices are slowly evolving.

This white paper explores what the future holds for clinical trials and how the process might evolve over the next 10 years.

Authored by Graham Belgrave, Senior Vice President, Global, Medical & Regulatory Affairs, and Managing Director, Europe at Advanced Clinical, the white paper also features co-founder of CORTS, the Center of Outcomes Research and Telemedicine Switzerland in Zurich, Dr Wolfgang Renz, and Mike Rea, CEO of IDEA Pharma.

Between them they discuss potential changes to how companies find, access and treat patients, and look at how innovations such as e-consent, virtual trials and electronic data capture will help.

Screenshot (1070)